4 Einträge gefunden

1. Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT

   1. Masouridi-Levrat, Stavroula
   2. Olavarria, Eduardo
   3. Iacobelli, Simona
   4. Aljurf, Mahmoud
   5. Morozova, Elena
   6. Niittyvuopio, Riitta
   7. Sengeloev, Henrik

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Correction to: Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party

   1. Schetelig, Johannes
   2. Chevallier, Patrice
   3. van Gelder, Michel
   4. Hoek, Jennifer
   5. Hermine, Olivier
   6. Chakraverty, Ronjon
   7. Browne, Paul

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party

   1. Schetelig, Johannes
   2. Chevallier, Patrice
   3. van Gelder, Michel
   4. Hoek, Jennifer
   5. Hermine, Olivier
   6. Chakraverty, Ronjon
   7. Browne, Paul

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
4. Melphalan 140mg/m2 or 200mg/m2 for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic Malignancies Working Party

   1. Auner, Holger W
   2. Iacobelli, Simona
   3. Sbianchi, Giulia
   4. Knol-Bout, Cora
   5. Blaise, Didier
   6. Russell, Nigel H
   7. Apperley, Jane F

   2018 - Forschungsinformationssystem des UKE - frei zugänglich